SEC Form 4 · accession 0001225208-16-027765
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 12:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2016 | A | 37,223 | $50.77 | A | 37,223 | D | |
| Common StockF2 | holding | — | — | — | 92,993 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.
- F2Holdings include shares acquired in dividend reinvestment transactions.